• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AVRO

AVRO

AVROBIO, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.40

-0.02 (-1.41%)

Company Profile

CEO

Erik John Ostrowski

IPO Date

2018-06-21

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.43

Prev. Close

$1.42

Day Low

$1.38

Day High

$1.44

52W Low

$1.38

52W High

$19.80

Market Cap

$0.01B

Volume

0.20M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

26.0%

Avg Negative

30.7%

Avg Neutral

43.2%

News Feed

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AVROBIO, Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile Corp·5/12/2021·↓ negative

Is a Surprise Coming for AVROBIO (AVRO) This Earnings Season?

Zacks Investment Research·5/12/2021·↑ positive

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against AVROBIO, Inc. and Encourages Investors with Losses to Contact the Firm

PRNewsWire·5/6/2021·↓ negative

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AVROBIO, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire·5/5/2021·↓ negative

AVROBIO: Fabrazyme's Full Approval Changes Things

Seeking Alpha·5/5/2021·↑ positive

BREAKING ALERT: Rosen Law Firm Encourages AVROBIO, Inc. Investors with Losses to Inquire About Class Action Investigation – AVRO

Business Wire·5/4/2021·↓ negative

Avrobio Plans Registration Trial With Kidney Biopsy Endpoint To Support Potential Full Approval Of Fabry Disease Gene Therapy

Benzinga·5/3/2021·↑ positive

AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease

Business Wire·5/3/2021·↑ positive

Avrobio's Cystinosis Gene Therapy Gets Orphan Drug Status In Europe

Benzinga·3/1/2021·↑ positive

Avrobio: An Update After Stock Price Drop After bluebird Trial Halt

Seeking Alpha·2/17/2021·↓ negative